4.7 Article

Altering the distribution of Foxp3+ regulatory T cells results in tissue-specific inflammatory disease

Journal

JOURNAL OF EXPERIMENTAL MEDICINE
Volume 204, Issue 6, Pages 1335-1347

Publisher

ROCKEFELLER UNIV PRESS
DOI: 10.1084/jem.20070081

Keywords

-

Funding

  1. NCI NIH HHS [T32 CA09537, T32 CA009537] Funding Source: Medline
  2. NIAID NIH HHS [R56 AI067750, R01 AI067750, AI067750] Funding Source: Medline
  3. NIDDK NIH HHS [R01 DK072295, DK072295] Funding Source: Medline

Ask authors/readers for more resources

CD4(+)Foxp3(+) regulatory T cells (T reg) are essential for maintaining self-tolerance, but their functional mechanisms and sites of action in vivo are poorly defined. We examined the homing receptor expression and tissue distribution of T reg cells in the steady state and determined whether altering their distribution by removal of a single chemokine receptor impairs their ability to maintain tissue-specific peripheral tolerance. We found that T reg cells are distributed throughout all nonlymphoid tissues tested, and are particularly prevalent in the skin, where they express a unique CCR4(+)CD103(hi) phenotype. T reg cell expression of CCR4 and CD103 is induced by antigen-driven activation within subcutaneous lymph nodes, and accumulation of T reg cells in the skin and lung airways is impaired in the absence of CCR4 expression. Mice with a complete loss of CCR4 in the T reg cell compartment develop lymphocytic infiltration and severe inflammatory disease in the skin and lungs, accompanied by peripheral lymphadenopathy and increased differentiation of skin-tropic CD4(+)Foxp3(-) T cells. Thus, selectively altering T reg cell distribution in vivo leads to the development of tissue-specific inflammatory disease.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available